Myelin injury and degraded myelin vesicles in Alzheimer's disease

Current Alzheimer Research

Volumn 11, Issue 3, 2014, Pages 232-238

  Zhan, Xinhua ^a   Jickling, Glen C ^a   Ander, Bradley P ^a   Liu, Dazhi ^a   Stamova, Boryana ^a   Cox, Christopher ^a   Jin, Lee Way ^a,b   DeCarli, Charles ^a,b   Sharp, Frank R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's; Corpora amylacea; Ependyma; Myelin basic protein; Myelin degradation

Indexed keywords

GALACTOSYLCERAMIDE; MYELIN; MYELIN BASIC PROTEIN;

ALZHEIMER DISEASE; ARTICLE; AXONAL INJURY; BRAIN TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; DEGRADATION; EPENDYMA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; NEUROFILAMENT; PRIORITY JOURNAL; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CEREBRAL VENTRICLES; FEMALE; HUMANS; MALE; MYELIN BASIC PROTEIN; MYELIN SHEATH; NEUROFILAMENT PROTEINS;

EID: 84897428674     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205011666140131120922     Document Type: Article

References (42)

1. Wallin A, Gottfries CG, Karlsson I, Svennerholm L. Decreased myelin lipids in Alzheimer's disease and vascular dementia. Acta Neurol Scand 80: 319-23 (1989).
2. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol 60: 393-8 (2003).
3. Chia LS, Thompson JE, Moscarello MA. X-ray diffraction evidence for myelin disorder in brain from humans with Alzheimer's disease. Biochim Biophys Acta 775: 308-12 (1984).
4. de la Monte SM. Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol 25: 450-9 (1989).
5. Englund E, Brun A, Alling C. White matter changes in dementia of Alzheimer's type. Biochemical and neuropathological correlates. Brain 111(Pt 6): 1425-39 (1988).
6. Han X, D MH, McKeel DW, Jr., Kelley J, Morris JC. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 82: 809-18 (2002).
7. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 25: 5-18; author reply 49-62 (2004).
8. Gottfries CG, Karlsson I, Svennerholm L. Membrane components separate early-onset Alzheimer's disease from senile dementia of the Alzheimer type. Int Psychogeriatr 8: 365-72 (1996).
9. Alzheimer A, Forstl H, Levy R. On certain peculiar diseases of old age. Hist Psychiatry 2: 71-101 (1991).
10. Moller HJ, Graeber MB. The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections. Eur Arch Psychiatry Clin Neurosci 248: 111-22 (1998).
11. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977-81 (1993).
12. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-3 (1993).
13. Satoi H, Tomimoto H, Ohtani R, Kitano T, Kondo T, Watanabe M, et al. Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis. Neuroscience 130: 657-66 (2005).
14. Mielke MM, Lyketsos CG. Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets? Neuromolecular Med 12: 331-40 (2010).
15. Lee DY, Fletcher E, Martinez O, Ortega M, Zozulya N, Kim J, et al. Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology 73: 1722-8 (2009).
16. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18: 351-7 (1997).
17. Alder N. On the nature, origin and distribution of the corpora amylacea of the brain with observations on some new staining reactions. J Ment Sci 99: 689-97 (1953).
18. Renkawek K, Bosman GJ. Anion exchange proteins are a component of corpora amylacea in Alzheimer disease brain. Neuroreport 6: 929-32 (1995).
19. Wilhelmus MM, Verhaar R, Bol JG, van Dam AM, Hoozemans JJ, Rozemuller AJ, et al. Novel role of transglutaminase 1 in corpora amylacea formation? Neurobiol Aging 32: 845-56 (2011).
20. Cisse S, Perry G, Lacoste-Royal G, Cabana T, Gauvreau D. Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains. Acta Neuropathol 85: 233-40 (1993).
21. Ihara M, Polvikoski TM, Hall R, Slade JY, Perry RH, Oakley AE, et al. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol 119: 579-89 (2010).
22. Peters A, Moss MB, Sethares C. Effects of aging on myelinated nerve fibers in monkey primary visual cortex. J Comp Neurol 419: 364-76 (2000).
23. Nielsen K, Peters A. The effects of aging on the frequency of nerve fibers in rhesus monkey striate cortex. Neurobiol Aging 21: 621-8 (2000).
24. Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke 39: 1127-33 (2008).
25. Peters A. The effects of normal aging on myelinated nerve fibers in monkey central nervous system. Front Neuroanat 3: 11 (2009).
26. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19: 253-62 (1986).
27. Roher AE, Weiss N, Kokjohn TA, Kuo YM, Kalback W, Anthony J, et al. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 41: 11080-90 (2002).
28. Umahara T, Tsuchiya K, Ikeda K, Kanaya K, Iwamoto T, Takasaki M, et al. Demonstration and distribution of tau-positive glial coiled body-like structures in white matter and white matter threads in early onset Alzheimer's disease. Neuropathology 22: 9-12 (2002).
29. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307: 1282-8 (2005).
30. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 58: 1395-402 (2001).
31. Kirkpatrick JB, Hayman LA. White-matter lesions in MR imaging of clinically healthy brains of elderly subjects: possible pathologic basis. Radiology 162: 509-11 (1987).
32. Candelario-Jalil E, Thompson J, Taheri S, Grossetete M, Adair JC, Edmonds E, et al. Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment. Stroke 42: 1345-50 (2011).
33. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64: 575-611 (2001).
34. Kalaria RN. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther 72: 193-214 (1996).
35. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12: 723-38 (2011).
36. Horsburgh K, Reimer MM, Holland P, Chen G, Scullion G, Fowler JH. Axon-glial disruption: the link between vascular disease and Alzheimer's disease? Biochem Soc Trans 39: 881-5 (2011).
37. Scheltens P, Barkhof F, Leys D, Wolters EC, Ravid R, Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology 45: 883-8 (1995).
38. Miklossy J, Kraftsik R, Pillevuit O, Lepori D, Genton C, Bosman FT. Curly fiber and tangle-like inclusions in the ependyma and choroid plexus--a pathogenetic relationship with the cortical Alzheimer-type changes? J Neuropathol Exp Neurol 57: 1202-12 (1998).
39. Barnum SR. Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 6: 132-46 (1995).
40. Radojicic M, Nistor G, Keirstead HS. Ascending central canal dilation and progressive ependymal disruption in a contusion model of rodent chronic spinal cord injury. BMC neurology 7: 30 (2007).
41. Hoarau JJ, Krejbich-Trotot P, Jaffar-Bandjee MC, Das T, Thon-Hon GV, Kumar S, et al. Activation and control of CNS innate immune responses in health and diseases: a balancing act finely tuned by neuroimmune regulators (NIReg). CNS & Neurol Disord Drug Targets 10: 25-43 (2011).
42. Hamilton LK, Aumont A, Julien C, Vadnais A, Calon F, Fernandes KJ. Widespread deficits in adult neurogenesis precede plaque and tangle formation in the 3xTg mouse model of Alzheimer's disease. Eur J Neurosci 32: 905-20 (2010).